. 2021 Jan 13;14(1):60. doi: 10.3390/ph14010060

Table 1.

Putative cancer stem cell markers for tumors of diverse histological origin.

Tumor	Markers	References
Acute Myeloid Leukemia	CD34⁺/CD38⁻	[6,21]
Breast	CD44^high/CD24^low	[20]
Ovary	CD24⁺, CD133⁺, CXCR4⁺	[25,42]
Ewing’s Sarcoma	CD133⁺	[29]
Lung	CD133⁺, CD90⁺	[43]
Prostate	CD44⁺/α2β1integrin^high/CD133⁺	[44]
Colorectal	CD44⁺, CD133⁺, CD166⁺, Lgr5⁺, EpCAM⁺	[45]
Pancreas	CD44⁺, CD24⁺, EpCAM⁺	[46]
Brain	CD90⁺, CD133⁺	[47,48]
Melanoma	CD271⁺	[49]

Putative cancer stem cells may be identified by surface markers dependent on the histological origin of the tumor. CD: Complex of Differentiation; CXCR4: C-X-C chemokine receptor type 4; EpCam: Epithelial Cell Adhesion Molecule; Lgr5: Leucine-rich repeat-containing G-protein coupled receptor 5.